Saturday, February 4, 2023 | Back issues
Courthouse News Service Courthouse News Service

EpiPen Class Action

A federal court in Kansas ruled partially in favor of Mylan in a class action suit brought by EpiPen consumers. The court granted Mylan summary judgment on RICO claims and antitrust claims based on rebate agreements but claims based on a settlement agreement with generic drug manufacturer Teva in 2012 will continue to trial.

KANSAS CITY, Kan. — A federal court in Kansas ruled partially in favor of Mylan in a class action suit brought by EpiPen consumers. Mylan won summary judgment on claims that its rebate agreements violated federal anti-racketeering and antitrust law, but claims based on a 2012 settlement agreement with generic drug manufacturer Teva will continue to trial. 

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.

Loading
Loading...